A vaccine against Covid-19 placed on the Sanofi logo.

-

ALLILI MOURAD

It's a small compensation for Sanofi.

For the moment being unable to offer its own vaccine against Covid-19, the French laboratory will bottle that of its competitors Pfizer and BioNTech and package more than 100 million doses this year.

The announcement of this boost was made Tuesday by Sanofi CEO Paul Hudson after the French government asked him several times, recently, to make its production lines available to its competitors.

In an interview published on the

Figaro website

, Paul Hudson explains that Sanofi will use its German factory in Frankfurt to package the vaccine, which will be supplied to it by its competitors from July.

"This production site being located near the headquarters of BioNTech [in Mainz], this will make things easier", argues the boss of the French group.

The production will be destined for the European Union, and therefore partly for France, he added.

This agreement comes at a time when several laboratories are encountering difficulties in maintaining the high speeds necessary in order to respect the contracts they have signed.

The calendar according to Paul Hudson

Regarding his own vaccine projects, Paul Hudson ensures that the recombinant protein one, a technology that Sanofi uses for its influenza vaccine, "is progressing well", despite a few months of delay and should arrive on the market in the last quarter of 2021. According to him, such a launch window makes sense because there will still be people to be vaccinated around the world at that time.

On the other hand, while several variants of the virus responsible for Covid-19 have been identified and questions remain concerning the effectiveness of vaccines already marketed against them, he considers that this technology "could be more effective against these mutations As messenger RNA.

The French laboratory is still developing a vaccine based on this latest technology, used in particular by Pfizer and BioNTech, in partnership with an American biotech.

"We think we can enter the clinical phase with an RNA vaccine against Covid from the first quarter of this year", hopes Paul Hudson.

Health

Delays in delivery of AstraZeneca vaccines "not acceptable" denounces the European Union

Health

Pasteur stops his main vaccine project, not effective enough

  • Covid 19

  • Pharmaceutical industry

  • Coronavirus

  • Health

  • Video

  • Anti-covid vaccine

  • Sanofi